Tempest Therapeutics, Inc. — Director's Dealing 2021

Sep 21, 2021

SEC Form 4/A — Form 4/A

Issuer: Tempest Therapeutics, Inc. (TPST)
CIK: 0001544227
Period of Report: 2021-07-01

Reporting Person: NICHOL GEOFFREY (Director)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2021-07-01	Stock Option (Right to Buy)	$11.07	A	6635	Acquired	2031-06-30	Common Stock (6635)	Direct

Footnotes

F1: Vests over three (3) years, with one-third (1/3) of the award vesting on the first anniversary of the grant date and the remainder of the award vesting in equal monthly installments thereafter, subject to the reporting person's continuous service through each vesting date.